The Role of the Oxidative State and Innate Immunity Mediated by TLR7 and TLR9 in Lupus Nephritis

被引:6
|
作者
Echavarria, Raquel [1 ,2 ]
Cardona-Munoz, Ernesto German [3 ]
Ortiz-Lazareno, Pablo [1 ]
Andrade-Sierra, Jorge [3 ]
Gomez-Hermosillo, Luis Francisco [3 ]
Casillas-Moreno, Jorge [3 ]
Campos-Bayardo, Tannia Isabel [3 ]
Roman-Rojas, Daniel [3 ]
Garcia-Sanchez, Andres [3 ]
Miranda-Diaz, Alejandra Guillermina [3 ]
机构
[1] Inst Mexicano Seguro Social, Ctr Invest Biomed Occidente, Guadalajara 44340, Mexico
[2] Consejo Nacl Ciencia & Tecnol CONACYT, Mexico City 03940, Mexico
[3] Univ Guadalajara, Univ Ctr Hlth Sci, Dept Physiol, Guadalajara 44360, Mexico
关键词
systemic lupus erythematosus; lupus nephritis; antioxidants; oxidative stress; DNA damage; mitochondrial function; mitophagy; TOLL-LIKE RECEPTORS; B-CELL TOLERANCE; NITRIC-OXIDE; DENDRITIC CELLS; URIC-ACID; VITAMIN-D; MITOCHONDRIAL BIOGENESIS; METABOLIC CHECKPOINT; ANTIVIRAL RESPONSES; LIPID-PEROXIDATION;
D O I
10.3390/ijms242015234
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) and is considered one of the leading causes of mortality. Multiple immunological pathways are involved in the pathogenesis of SLE, which makes it imperative to deepen our knowledge about this disease's immune-pathological complexity and explore new therapeutic targets. Since an altered redox state contributes to immune system dysregulation, this document briefly addresses the roles of oxidative stress (OS), oxidative DNA damage, antioxidant enzymes, mitochondrial function, and mitophagy in SLE and LN. Although adaptive immunity's participation in the development of autoimmunity is undeniable, increasing data emphasize the importance of innate immunity elements, particularly the Toll-like receptors (TLRs) that recognize nucleic acid ligands, in inflammatory and autoimmune diseases. Here, we discuss the intriguing roles of TLR7 and TLR9 in developing SLE and LN. Also included are the essential characteristics of conventional treatments and some other novel and little-explored alternatives that offer options to improve renal function in LN.
引用
收藏
页数:27
相关论文
共 50 条
  • [41] Differences in codon bias and GC content contribute to the balanced expression of TLR7 and TLR9
    Newman, Zachary R.
    Young, Janet M.
    Ingolia, Nicholas T.
    Barton, Gregory M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (10) : E1362 - E1371
  • [42] Activation of a TLR9 mediated innate immune response in preeclampsia
    Rachel D. Williamson
    Fergus P. McCarthy
    Louise C. Kenny
    Cathal M. McCarthy
    Scientific Reports, 9
  • [43] Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development
    Mohamed, Fatma El Zahraa
    Jalan, Rajiv
    Minogue, Shane
    Andreola, Fausto
    Habtesion, Abeba
    Hall, Andrew
    Winstanley, Alison
    Damink, Steven Olde
    Malago, Massimo
    Davies, Nathan
    Luong, Tu Vinh
    Dhillon, Amar
    Mookerjee, Rajeshwar
    Dhar, Dipok
    Al-Jehani, Rajai Munir
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (05) : 1806 - 1821
  • [44] Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes
    Akilesh, Holly M.
    Buechler, Matthew B.
    Duggan, Jeffrey M.
    Hahn, William O.
    Matta, Bharati
    Sun, Xizhang
    Gessay, Griffin
    Whalen, Elizabeth
    Mason, Michael
    Presnell, Scott R.
    Elkon, Keith B.
    Lacy-Hulbert, Adam
    Barnes, Betsy J.
    Pepper, Marion
    Hamerman, Jessica A.
    SCIENCE, 2019, 363 (6423) : 142 - 142
  • [45] Activation of a TLR9 mediated innate immune response in preeclampsia
    Williamson, Rachel D.
    McCarthy, Fergus P.
    Kenny, Louise C.
    McCarthy, Cathal M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [46] EXPRESSION AND FUNCTION OF TOLL LIKE RECEPTORS TLR4, TLR7 AND TLR9 IN CLASSICAL HODGKIN LYMPHOMA
    Xu, C.
    Visser, L.
    Diepstra, A.
    Moeller, P.
    Poppema, S.
    van den Berg, A.
    HAEMATOLOGICA, 2010, 95 : S4 - S4
  • [47] TLR9 and HHV-6: innate immunity in multiple sclerosis
    Alvarez-Lafuente, R.
    Lopez-Cavanillas, M.
    Garcia-Montojo, M.
    Cenit, M. C.
    Dominguez-Mozo, M. I.
    Martinez, A.
    De Las Heras, V.
    Garcia-Martinez, A.
    De La Concha, E. G.
    Bartolome, M.
    Urcelay, E.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S194 - S194
  • [48] Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
    Cascini, Caterina
    Ratti, Chiara
    Botti, Laura
    Parma, Beatrice
    Cancila, Valeria
    Salvaggio, Adriana
    Meazza, Cristina
    Tripodo, Claudio
    Colombo, Mario P.
    Chiodoni, Claudia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [49] Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma
    Caterina Cascini
    Chiara Ratti
    Laura Botti
    Beatrice Parma
    Valeria Cancila
    Adriana Salvaggio
    Cristina Meazza
    Claudio Tripodo
    Mario P. Colombo
    Claudia Chiodoni
    Journal of Experimental & Clinical Cancer Research, 42
  • [50] Cross-regulation between TLR7, TLR8, and TLR9 in autoreactive B cells.
    Green, Nathaniel
    Debatis, Michelle
    Marshak-Rothstein, Ann
    JOURNAL OF IMMUNOLOGY, 2011, 186